Manufacturer record
Kerala Medical Services Corporation Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
24 batches manufactured by Kerala Medical Services Corporation Ltd (Kerala) were declared Not of Standard Quality between August 2024 and April 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
24 records linked to Kerala Medical Services Corporation Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
0Banned or prohibited
0Recalled or suspended
24Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
24
NSQ batches since 2024
13
Products affected
Other
Most common failure
Apr 2025
Latest alert
Flagged batches per year
2024 · 82025 · 16
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Telmisartan Tab IP 40 mg | D0004/25-26Mfg ? · Exp ? | The sample does not conform to IP standards with respect to descriptive part for tabletsOther | DTL ThiruvananthapuramState lab | Apr 2025 |
| Paracetamol Tab IP 500 mg | D 0001/25-26Mfg ? · Exp ? | It fails the tests dissolution as per IP specified in the Laboratory ProtocolDissolution | DTL ThiruvananthapuramState lab | Apr 2025 |
| Gentamicin Inj. IP | D0003/25-26Mfg ? · Exp ? | It fails the test particulate matter and descriptive part for injectionsParticulate matter | DTL ThiruvananthapuramState lab | Apr 2025 |
| Paracetamol Tabl IP 500 mg | D 3213/24 -25Mfg ? · Exp ? | It fails the tests dissolution specified in the Laboratory ProtocolDissolution | Drugs Testing Laboratory ThiruvananthapuramState lab | Mar 2025 |
| Paracetamol Tab IP 500 mg | D 2999/24 -25Mfg ? · Exp ? | It fails the tests dissolution specified in the Laboratory ProtocolDissolution | Drugs Testing Laboratory ThiruvananthapuramState lab | Mar 2025 |
| Paracetamol Tab IP 500 mg | D 3212/24 -25Mfg ? · Exp ? | It fails the tests dissolution specified in the Laboratory ProtocolDissolution | Drugs Testing Laboratory ThiruvananthapuramState lab | Mar 2025 |
| Paracetamol Tab IP 500 mg | D 3103/24 -25Mfg ? · Exp ? | It fails the tests for dissolution and descriptive part for tablets as specified in the Laboratory Protocol as per IPDissolution | Drugs Testing Laboratory ThiruvananthapuramState lab | Mar 2025 |
| Vitamin B Complex Tablets N.F.I | S0018/2 4-25Mfg ? · Exp ? | The sample does not conform to IP standards to Descriptive part for tablets As per IP, the tablets should have sufficient hardness to withstand handling without crumbling or breaking. The tablets are soft and in powdered form and cannot be removed from strip in intact form and further tests cannot be performed for the reason specified in the laboratory protocol.Other | DTL ThiruvananthapuramState lab | Feb 2025 |
| Vitamin B Complex Tablets N.F.I | S0017/2 4-25Mfg ? · Exp ? | The sample does not conform to IP standards to Descriptive part for tablets As per IP, the tablets should have sufficient hardness to withstand handling without crumbling or breaking. The tablets are soft and in powdered form and cannot be removed from strip in intact form and further tests cannot be performed for the reason specified in the laboratory protocol.Other | DTL ThiruvananthapuramState lab | Feb 2025 |
| Clopidogrel Tab IP 75 mg | D 2720/24 -25Mfg ? · Exp ? | It fails the test ?Dissolution?, ?Assay? and descriptive part for tablets specified above as per IPAssay | DTL ThiruvananthapuramState lab | Feb 2025 |
| Cefixime Oral Suspension IP 100 mg/5ml | D2852/2 4-25Mfg ? · Exp ? | It fails the test ?Assay? and ?Descriptive part? for oral powders specified above as per IPAssay | DTL ThiruvananthapuramState lab | Feb 2025 |
| Vitamin B Complex Tablets NFI | S0016/24 -25Mfg ? · Exp ? | The sample does not conform to IP standards with respect to ?Descriptive Part? for tablets.Other | DTL ThiruvananthapuramState lab | Jan 2025 |
| Losartan Potassium Tab IP 25 mg | D 2615/24- 25Mfg ? · Exp ? | It fails the ?Descriptive Part? for the tablets as per IP , tablets should have sufficient hardness for handling without crumbling and breakingOther | DTL ThiruvananthapuramState lab | Jan 2025 |
| Glimepiride Tablet IP 1 mg | D2721/24 -25Mfg ? · Exp ? | The sample does not conform to IP standards with respect to ?Descriptive Part? for tablets.Other | DTL ThiruvananthapuramState lab | Jan 2025 |
| Glimepiride Tablet IP 1 mg | D2505/24 -25Mfg ? · Exp ? | It fails the test dissolution and ?Descriptive Part? specified in the Laboratory Protocol as per IPDissolution | DTL ThiruvananthapuramState lab | Jan 2025 |
| Glimepiride Tablet IP | D2854/24 -25Mfg ? · Exp ? | The sample does not conform to IP standards with respect to ?Descriptive Part? for tablets.Other | DTL ThiruvananthapuramState lab | Jan 2025 |
| Paracetamol Tab IP 500 mg. | D2370/24- 25Mfg ? · Exp ? | It fails the test ?Dissolution? as per IPDissolution | DTL ThiruvananthapuramState lab | Dec 2024 |
| Metformin Hydrochloride Sustained Release Tab IP 500 mg | D2164/24-25Mfg ? · Exp ? | It fails the test microbial contamination in Non-sterile products and Descriptive part for tablets as per IPMicrobial limits | DTL ThiruvananthapuramState lab | Dec 2024 |
| Glimepiride Tab IP 1 mg | D1885/24- 25Mfg ? · Exp ? | Does not conform to IP standards with respect to descriptive partOther | DTL ThiruvananthapuramState lab | Nov 2024 |
| Telmisartan Tab IP 40 mg | D1153/24-25Mfg ? · Exp ? | The sample does not conform to IP Standards with respective to ?Descriptive part? of tablets and further tests cannot be performed due to above reasons.Other | DTL ThiruvananthapuramState lab | Sep 2024 |
| Pantoprazole Inj.BP 40 mg | D 0923/24- 25Mfg ? · Exp ? | It fails the test ?Sterility? specified in the laboratory protocol as per IPSterility | DTL ThiruvananthapuramState lab | Sep 2024 |
| Glimepiride Tab IP | D1272/24-25Mfg ? · Exp ? | The sample fails the descriptive part for tablets as they are not sufficiently hard to withstand handling without crumbling or breaking and further tests cannot be performed due to above reasonOther | DTL ThiruvananthapuramState lab | Sep 2024 |
| Cough Syrup | D 1278/24- 25Mfg ? · Exp ? | The sample fails the ?Descriptive part? for oral dosage forms of Schedule V of drugs and cosmetics Act and Rules, as the syrup contains red coloured suspended paticlesDescription | DTL ThiruvananthapuramState lab | Sep 2024 |
| Pantoprazole Inj. BP 40 mg | D0726/24- 25Mfg ? · Exp ? | The sample does not comply with BP. It fails the test Particulate contaminatio n clarity and colour of solution.Particulate matter | DTL ThiruvananthapuramState lab | Aug 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.